Oyster Point Pharma, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €21.14M +∞% -€89.94M +48.0% -425.4% -4.3 pp -€75.72M +52.3% -358.1% -3.6 pp
    €0.00 +NaN% -€60.76M +54.3% N/A -€49.71M +42.1% N/A
    €0.00 +NaN% -€39.38M +177.0% N/A -€34.99M +137.8% N/A
    €0.00 +NaN% -€14.22M +150.0% N/A -€14.72M +265.5% N/A
    €0.00 -€5.69M N/A -€4.03M N/A

    Notifications